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The Role 18F-FDG and 18F-NaF PET/CT in Assessment of
Temporomandibular Joint Metabolic Activity in Rheumatoid Arthritis
Abstract
Objective: The aim of this study was to evaluate the efficacy of 18F-fluorodeoxyglucose (FDG) and 18F-
sodium fluoride (NaF)PET/CT for assessing the status of the temporomandibular joint (TMJ) of
rheumatoid arthritis (RA) patients compared with healthy (non-RA) individuals.
Method:
Eighteen patients diagnosed with RA (mean age 55±12.1years: 4 females and 14 males) were included in the
test group. Eighteen age-, sex- and race-matched healthy control subjects were selected from the CAMONA
clinical trial. PET/CT images were acquired 180-minute post-intravenous administration of FDG and NaF
(2.2 MBq/kg). For FDG analysis, regions of interest (ROIs) were manually assigned per anatomical
boundaries using a closed polygon tool. The first ROI of the mask was assigned on the trans-axial CT slice
with the first evidence of the glenoid fossa down to two to three slices inferiorly. The ROI followed the
anatomy of the TMJ. For NaF, a three-dimensional ball tool of 1.5 cm was used to assign ROIs with the head
of the mandibular condyle located at the center including the osseous compartment of the joint extending
inferiorly to the neck of the condyle. Averaged SUVmean was used to semi-quantify FDG and NaF uptake in
each joint. Then average SUVmean of the right and the left TMJ was determined. For normalization, a Target
to Background Ratio (TBR) was used. For statistical analysis, the student’s t-test and regression analysis were
used. The severity of RA was assessed by determining the Disease Activity Score of serum C reactive protein
(DAS-28 CRP) and erythrocyte sedimentation rate (DAS-28 ESR) for each subject.
Results:
FDG TBRmean for the test group was 1.21±0.33 compared to 0.91±0.2 in controls, (p=0.003.) No
correlation was found between FDG uptake and DAS28-CRP or DAS28-ESR. The NaF average SUVmean
was significantly higher in RA patients than healthy control subjects (2.4±0.8 versus 1.9±0.4, p=0.02).
Similarly, the TMJ TBRmean was also higher in RA patients relative to healthy controls (4.2±2.1 versus
2.7±0.9, p=0.01) A significant positive correlation was found between TBRmean and DAS28-CRP (r=0.49,
p=0.03), while there was positive trend in the correlation between TBRmean with DAS28-ESR that was not
statistically significance (r=0.37, p=0.12).
Conclusion:
RA patients appear to have significantly higher metabolic activity in the TMJ than age-, sex- and race-matched
healthy control subjects. Our results illustrate the potential value of using FDG and NaF-PET/CT for
evaluation of TMJ disorders and suggest that this modality may useful for monitoring the effects of treatment
regimens.
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Abstract:  
 
Objective: The aim of this study was to evaluate the efficacy of 18F-
fluorodeoxyglucose (FDG) and 18F-sodium fluoride (NaF)PET/CT for assessing 
the status of the temporomandibular joint  (TMJ) of rheumatoid arthritis (RA) 
patients compared with healthy (non-RA) individuals. 
Method:  
Eighteen patients diagnosed with RA (mean age 55±12.1years: 4 females and 14 
males) were included in the test group. Eighteen age-, sex- and race-matched 
healthy control subjects were selected from the CAMONA clinical trial. PET/CT 
images were acquired 180-minute post-intravenous administration of FDG and 
NaF (2.2 MBq/kg). For FDG analysis, regions of interest (ROIs) were manually 
assigned per anatomical boundaries using a closed polygon tool. The first ROI of 
the mask was assigned on the trans-axial CT slice with the first evidence of the 
glenoid fossa down to two to three slices inferiorly. The ROI followed the anatomy 
of the TMJ. For NaF, a three-dimensional ball tool of 1.5 cm was used to assign 
ROIs with the head of the mandibular condyle located at the center including the 
osseous compartment of the joint extending inferiorly to the neck of the condyle. 
Averaged SUVmean was used to semi-quantify FDG and NaF uptake in each joint. 
Then average SUVmean of the right and the left TMJ was determined. For 
normalization, a Target to Background Ratio (TBR) was used. For statistical 
analysis, the student’s t-test and regression analysis were used. The severity of RA 
was assessed by determining the Disease Activity Score of serum C reactive 
protein (DAS-28 CRP) and erythrocyte sedimentation rate (DAS-28 ESR) for each 
subject.  
Results:  
FDG TBRmean for the test group was 1.21±0.33 compared to 0.91±0.2 in controls, 
(p=0.003.) No correlation was found between FDG uptake and DAS28-CRP or 
DAS28-ESR. The NaF average SUVmean was significantly higher in RA patients 
than healthy control subjects (2.4±0.8 versus 1.9±0.4, p=0.02). Similarly, the TMJ 
TBRmean was also higher in RA patients relative to healthy controls (4.2±2.1 
versus 2.7±0.9, p=0.01) A significant positive correlation was found between 
TBRmean and DAS28-CRP (r=0.49, p=0.03), while there was positive trend in the 
correlation between TBRmean with DAS28-ESR that was not statistically 
significance (r=0.37, p=0.12).  
 
Conclusion:  
RA patients appear to have significantly higher metabolic activity in the TMJ than 
age-, sex- and race-matched healthy control subjects. Our results illustrate the 
potential value of using FDG and NaF-PET/CT for evaluation of TMJ disorders 
and suggest that this modality may useful for monitoring the effects of treatment 
regimens.  
  
 
 
 
 
  
Introduction: 
Temporomandibular Joint:  
 The temporomandibular joint (TMJ) is a dynamic synovial joint that is 
formed by the articulation of the articular eminence and fossa of the temporal bone 
superiorly with the condylar head of the mandible inferiorly. In humans, the 
embryonic development of the joint starts at week 8 of gestation as evidenced by 
the appearance of bony and cartilaginous structures. The various components of 
the joint are derived from the first pharyngeal arch that contains a mesodermal 
component that yields the vasculature and musculature and neural crest 
mesenchyme that gives rise to the bony and cartilaginous portions. Three stages 
have been identified in normal TMJ development. The first (blastemic stage) is 
defined by the appearance of two blastemas. The glenoid fossa blastema, derived 
from the otic capsule, undergoes intramembranous bone ossification. The second 
blastema eventually gives rise to the condyle via endochondral bone formation. 
The second stage of TMJ development (cavitation stage) begins during weeks 9 to 
11 of gestation and is characterized by the presence of a mesenchymal layer that 
forms between the two blastemas that develops into the articular disc. The fibrous 
disc separates the space between the temporal bone and condyle into an upper and 
a lower compartment. The final stage (maturation stage) extends from the 17th 
week of gestation until birth culminating in the formation of the functional bony 
and cartilaginous elements of the joint.1,2,3,4 
 The temporomandibular joint is considered a ginglymoarthrodial joint 
characterized by the presence of a synovial cavity and articular disc. Unlike other 
joints, the articulating surfaces of the TMJ are covered by fibrous connective tissue 
containing cartilaginous cells.5,6 Anatomically, the fully developed TMJ consists of 
a concavity in the temporal bone referred to as the glenoid fossa that 
accommodates the condylar head of the mandible. The postglenoid process 
represents the posterior aspect of the joint and forms the anterior part of the 
external auditory meatus. The anterior aspect of the TMJ corresponds to the 
articular eminence of the zygomatic bone. Inferiorly, the articular surface of the 
joint is the superior border of the condylar head of the mandible.  
 
 In the middle of the joint a biconcave, non-vascular fibrous disc is located 
between the glenoid fossa and the condylar head with the thinnest portion in the 
middle. The disc is firmly attached to the medial and lateral parts of the condyle 
thereby facilitating the simultaneous movement of the two structures with every 
jaw movement. The upper part of the disc is attached to the posterior part of the 
glenoid fossa preventing it from slipping during jaw movement while the lower 
component helps avoid excessive rotation of disk relative to the condyle.  
  Numerous ligaments and muscles associated with the TMJ play major roles 
relative to jaw movements, force management and perception. The 
sphenomandibular, stylomandibular, pterygomandibular and collateral ligaments 
are among the ligaments involved in jaw movement and maintaining the proximity 
of the condyle to the temporal bone during mouth opening. The temporalis, 
masseter and medial pterygoid muscles are responsible for closing the jaw while 
opening involves the lateral pterygoid, geniohyoid, mylohyoid and digastric 
muscles. The arterial blood supply to the TMJ is mainly derived from the 
superficial temporal, anterior tympani, deep temporal, auricular posterior, 
transverse facial, middle meningeal and maxillary arteries. Venous drainage occurs 
through the pterygoid plexus that channels into the internal maxillary, 
sphenopalatine, medial meningeal, deep temporal, masseterine and inferior 
alveolar veins. The anteriolateral portion of the capsule of theTMJ is innervated by 
the masseteric nerve while the lateral aspect of the joint is innervated by 
auriculotemporal nerve. The masseteric and auriculotemporal nerves originate 
from the second and third branches of the trigeminal nerve, respectively. 
 
 The TMJ plays an important role a in a number of processes associated with 
the oral cavity. Amongst these are mouth opening/closing, chewing, speaking and 
swallowing. During mouth opening the condyle goes through a combination of 
rotational and translational movements.  
 
 Multiple pathological conditions can affect the TMJ and dramatically impact 
a patient’s life style. Disc displacement is a common joint derangement involving 
excessive movement of the disc anteriorly, medially or laterally but rarely 
posteriorly. Typically, the disc returns to its original position when the mouth is 
opened (reduction) while in a small percentage of subjects the displaced disc 
remains anterior to the condylar head (displacement without reduction). Severe 
forms of displacement can result in perforation of the disc that can be accompanied 
by osseous changes such as joint flattening and formation of osteophytes on the 
condyle and/or the articular surface of the temporal bone. Clinical manifestations 
of disc displacement include pain, clicking sounds and/or tenderness upon 
palpation of the joint and associated muscles. Treatment of a displaced disc ranges 
from conservative treatment (reassurance, occlusal adjustment, bite splints, 
administration of non-steroidal anti-inflammatory drugs (NSAID) and physical 
therapy) to more invasive types of interventions (arthroscopy, open surgery, 
condylectomy with or without bone grafting and alloplastic join replacement) 
depending upon the severity of a patient’s symptoms.  
 TMJ pathology is not limited to displacement of the articular disc. 
Conditions that can affect the TMJ resulting in various degrees of dysfunction are 
osteoarthritis (OA), rheumatoid arthritis (RA), psoriatic arthopathy, ankylosing 
spondylitis, fibromyalgia as well as tumor and tumor-like lesions, amongst others. 
Osteoarthritis is associated with breakdown of the cartilage and bone within a joint 
secondary to an inflammatory process.8 The diagnosis of OA is based on both 
clinical and radiographic findings. Clinically, patients complain of pain, tenderness 
upon palpitation of the TMJ and crepitus. Typical radiographic findings include, 
degenerative erosion of the head of the condyle and the glenoid fossa, condylar 
flattening and/or osteophyte formation.9 The clinical symptoms can be managed 
through physical therapy, asking the patient to avoid heavy forces on the joint by 
eating soft food and avoiding gum chewing, the use of occlusal appliances and 
administration of anti-inflammatory medications. 10 
 
 
 
Rheumatoid Arthritis: 
 Rheumatoid Arthritis (RA) is a chronic systemic autoimmune disease that 
primarily affects joints including the TMJ. The condition is mediated by an 
inflammatory reaction within synovial tissue leading to degeneration of cartilage 
and bone. The exact mechanism(s) underlying the pathogenesis of RA remain 
under investigation. Clinical signs and symptoms of RA are often preceded by the 
appearance of rheumatoid factor (RF; autoantibodies against the Fc region of IgG) 
and anti–citrullinated protein antibody (ACPA)11,12.  
 A local increase in the concentration of the proinflammatory cytokines 
Interleukin-1 (IL-1), Intereukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-
  derived from antigen-activated CD4+ T cell has been reported in RA patients. 
These cytokines, especially TNF-a and IL-1, are believed to have a key role in the 
pathogenies of RA. Both cytokines have been detected in the serum and synovial 
fluid of subjects with RA. Together, they can induce mesenchymal cells to release 
tissue destructive matrix metalloproteinases that participate in degenerative 
alterations within the joint. Activated CD4+ cells stimulate B cells to 
immunoglobulin-secreting plasma cells some which produce RF.13 Additionally, 
activated CD4+ cell expresss receptor activator of nuclear factor kappa-beta ligand 
(RANK) that interacts with it’s cognate receptor RANK found on the surface of 
immature and mature osteoclasts (OC). Interaction of RANKL with RANK 
stimulates osteoclastogenesis and activation of OCs that mediate resorption of the 
osseous component of the joint.14 Macrophages, lymphocytes and fibroblasts are 
also stimulated which can promote angiogenesis and consequently an increase in 
the vascularity of the synovium.   
 The overall prevalence of in US population RA ranges from 0.5 - 1% with 
women being affected two to three times more frequently than men. 11.16 
Epidemiologic studies have demonstrated variability in the prevalence of the 
disease between ethnic groups. For example, the estimated prevelance rate in Pima 
Indians was (5%), Chippewa Indians (6.8%), rural Africa (0.1%) and China/Japan 
(0.2%-0.3%). These differences suggest that both genetic and environmental 
factors contribute modulate the disease process.17 
 
 Diagnosis of RA is based on clinical, hematological and radiographic 
criteria. Clinical findings that are diagnostic for the diseases include joints pain, 
edema of three or more joints, morning joint stiffness and metacarpal or metatarsal 
joint involvement through positive squeeze test. The wrists, proximal 
interphalangeal, metacarpophalangeal, and metatarsophalangeal joints are 
commonly affected by RA while the  distal interphalangeal and spinal joints are 
usually spared. 10 
 
 Laboratory tests for RA should include a complete blood cell count with a 
differential, evaluation of serum RF/ACPA concentrations and determination of 
either the erythrocyte sedimentation rate (ESR) or serum C-reactive protein  (CRP) 
level. Elevated serum RF and ACPA are parts of the European League Against 
Rheumatism/American College of Rheumatology (EULAR/ACR) diagnostic 
criteria for RA.11 An increase in RF titer has been reported to be correlated with the 
risk of developing RA and increasing disease severity. A value of >100 IU/ml has 
26 times more risk of having the disease.12 Anti–citrullinated protein antibody can 
typically be detected in serum before the onset of clinical symptoms. Patients who 
are ACPA-positive tend to have more bone degeneration and severe progression 
compared to patients who tested negative. 18 
 
 
 Increases in ESR and serum CRP are general biomarkers that have been 
used by rheumatologists to develop indices to quantify disease activity in the 
joints. One of the most widely index is the Disease Activity Score of 28 joints that 
can be calculated in the context of the ESR (DAS28-ESR) or serum CRP level 
(DAS28-CRP) and used to quantify disease activity as well as assess the response 
to treatment. 8,20 Swelling and tenderness in a standard set of joints is determined 
along with a global health assessment scored on a scale of 0 to 100. Formulas that 
integrates these values along with the ESR or serum CRP level are then used to 
calculate the actual DAS. The cutoff measures of disease activity for both CRP and 
ESR recommended by ACR: High disease activity >5.1, low disease activity <3.2, 
remission <2.6.  
 
 The goal in management of RA is disease remission or low disease activity 
taking into consideration the cost of treatment. Pharmacological approaches 
comprising disease-modifying antirheumatic drugs (DMARDs), NSAIDs and 
glucocorticoids have been used to successfully treat RA. The drugs are often used 
in conjunction with to manage the disease. In the European League Against 
Rheumatism (EULAR) task force multiple synthetic, biologic and 
targeted synthetic  medication recommended for the management of RA. Some of 
the pharmacological drugs reported in this task force includes DMARDs 
(methotrexate) and glucocorticoids.23 
 
Temporomandibular joint and rheumatoid arthritis:  
  
  Thee TMJ is one of the body joints that can be affected by RA. In the ACR 
and EULAR meeting on classification of RA, the TMJ was identified as one of the 
joints that need to be considered in the classification system.11 When the TMJ is 
involved in RA it can result in patient discomfort, crepitation, stiffness and 
limitation in mouth opening 5.  Garrot in 1859 was the first to describe TMJ 
involvement in rheumatic disease 24.  The prevalence of TMJ involvement in 
cohorts of RA patients is variable and has been reported to range from 10-58 % of 
subjects.15,19 TMJ involvement can be examined clinically or radiographically. One 
of the most common structural imaging modalities used to evaluate the TMJ is the 
panoramic radiograph that provides a 2-dimensional view of the osseous structures 
within the joint. Currently, computed tomography (CT) and cone-beam computed 
tomography (CBCT) are considered the gold standards for imaging the TMJ. These 
methodologies  provide high resolution and accurate 3-dimenional images that can 
demonstrate osseous changes within the joint.  When deemed necessary, magnetic 
resonance imaging (MRI) can be used to evaluate soft tissue abnormalities in the 
joint. 25 
 
 
Imaging of temporomandibular joint:  
In 1895, Röntgen discovered the so-called “X-ray” and described a method for 
visualizing internal anatomical structures. His work provided the foundation for 
modern radiographic imaging. Since Röntgen’s scientific breakthrough,  numerous 
technological advances have been made taking the concept of x-ray examination of 
patients from a curiosity to a routine and vital component of dentistry and 
medicine. Recent major innovations include CT, CBCT, MRI and a variety of 
molecular imaging techniques. Conventional radiographs yield two-dimesional 
(2D) images that can delineate anatomical structures and to some extent, 
demonstrate anatomical anomalies or pathological changes. A major step forward 
occurred in 1973 with the introduction of CT,  a method that provides three-
dimentional (3D) images that can be used to evaluate anatomical structures in their 
transvers, coronal and sagittal dimensions. Although extremely useful for assessing 
hard tissues a drawback to CT is that it is not ideally suited for appraising soft 
tissues.  In response to this, MRI was developed and is now considered the method 
of choice for soft tissue imaging. When considering the pathogenesis of many 
diseases, it is critical to appreciate that cellular and molecular alterations occur in a 
tissue prior to the onset of discernible structural changes. In the context of 
treatment outcomes, it is undoubtedly more desirable to detect the earliest stages of 
a disease process as opposed to the subsequent gross anatomic changes. Thus, a 
significant limitation of CT and MRI is their relative inability to demonstrate 
subclinical stages of a disease process. Along a similar line of thought, efficacious 
treatment of many conditions starts at the cellular and molecular levels with 
subsequent favorable structural changes taking protracted periods of time to 
manifest themselves. If CT and/or MRI are used to gauge a patient’s response to a 
particular form of therapy it is feasible that the resultant images mislead a clinician 
to conclude that the therapy is not working and should either be increased in 
“intensity” or even discontinued when in fact, the treatment is having a desirable 
effect . Both situations can have highly undesirable outcomes for the patient. In 
recognition of this, research has led to the advent of functional imaging protocols 
that have the  capacity to detect subclinical cellular and molecular changes 
providing a diagnostic advantage over CT and MRI, Furthermore, it has been 
proposed that functional imaging can be used to effectively monitor physiological 
responses to therapeutic interventions.  
   
Over the last two decades, a number of functional imaging techniques have been 
introduced into medical radiology including optical imaging, magnetic resonace 
spectroscopy, functional magnetic resonance imaging (fMR imaging) and positron 
emission tomography (PET). Positron emission tomography involves the use of 
radioactive isotopes such as 99mTi, 123I 11C, 13N, 15O, 18F,  31Ga , 93Zr or 82Rb that 
are injected into the patient. 27,28 These isotopes are characterized by the ability to 
bind to different biological substrate without altering their activity, also theses 
Isotopes have relatively short half-lives and can be excreted from the body after 
variable period of time. The atoms of the isotopes are in an unstable state and 
exhibit a high level of energy. Their nuclei  are densely packed with protons and 
neutrons that undergo decay to arrive at a less energetic and more stable state. The 
rate of decay is usually determined by the half-life of isotopes, i.e., the time it takes 
for half of the original nuclei to decay. As the decay proceeds positrons (𝜷+) are 
emitted that annhilate after contact with an electron releasing two high energy two 
photons (𝛾 radiation) in two different directions. A cylindrical scintillation detector 
is used to to detect and measure the amount of 𝛾 radiation. Via sonogram the 
information is processed (coincidence process) for data correction and image 
reconstruction.  H 
 
On a cellular level, cells with high metabolic activity exhibit increases glucose 
uptake. Most of the common radionuclides can be easily incorporate into 
biological substrates such as glucose or H2O. The labeled substrates have short 
have lives and do not interfere with normal cellular processes when taken up by 
cells. 18Fluorine-fluorodeoxyglucose (18F-FDG) exhibits a high affinity for 
malignant and inflammatory cells due to their increased rate of glucose metabolism 
relative to other cells. For these reasons, it was used as the tracer in the first total 
human body PET scan done in 1976 by a group of investigators at University of 
Pennsylvania. They were able to detect uptake of the tracer in the brain, heart and 
kidneys. The effectiveness of 18F-FDG has been in validated in numerous 
subsequent investigations. One of the most important characteristics of 18F-FDG is 
the similarity to glucose in structure and function such that it  circulates, migrates 
and is transported into cells in the same manner as glucose via GLUT transport 
protein. Once inside cells, 18F-FDG is metabolized through the identical pathways 
used for glucose. As a result, 18F-FDG is incorporated into metabolically active 
cells including  inflammatory cells, cancer cells and proliferating cells in the 
kidneys, gland tissue or brain. Therefore, 18F-FDG -PET can detect localized 
inflammatory changes at the molecular level. The tracer is now commonly used in 
PET to evaluate soft tissues but is not considered ideal for detecting metabolic 
changes in hard tissue structures.   
Historically, 18F-NaF was utilized as a standard radiotracer for bone scans before it 
was replaced by technetium polyphosphonates that have more desirable physical 
properties.41 Due to its ability to interact with bone, it was shown that could be 
used as a tracer in PET 18F-NaF   to evaluate bone disease. The integration of 18F-
NaF   into hard tissues is highly dependent on blood flow to the bony structure 
where it can easily cross cellular membranes and be rapidly cleared from plasma.42   
After absorption into ninhydroxyapatite,
18
F rapidly replaces a hydroxyl group on 
the surface of the hydroxyapatite matrix (Ca
10
(PO
4
)
6
OH
2
) of bone to form 
fluoroapatite (Ca
10
(PO
4
)
6
F
2
).43 This extent of 
18
F incorporation is determined by the 
amount of bone affected by a malignant tumor or osteoblastic/osteoclastic 
activity.44 Moreover, the uptake of 18F-NaF into bone structure has been reported to 
be twice that achieved with Tc-99m and is also cleared from blood more rapidly 
than  Tc-99m.31 Due to these characteristics 18F-NaF is considered a reliable 
radiotracer in regards to detecting bone metastasis, bone cancers and metabolic 
bony lesions with inflammatory etiologies.  
Several imaging strategies have been used to evaluate the structures of the TMJ. 
One common approach is the panoramic radiograph due to the fact that most dental 
offices are equipped with Panorex units and the relatively low cost of the study. A 
major limitation of this type of radiograph is it provides only 2D views of the 
condyle, ramus and body of the mandible. It can be used to identify gross osseous 
structural changes but does not provide information regarding the soft tissue 
component of the joint. In a study using panoramic images to evaluate 97 patients 
diagnosed with juvenile idiopathic arthritis, 55% of the subjects were found to 
have radiographic evidence of hard tissue alterations of the TMJ. In individuals 
with clinical symptoms of joint pain and dysfunction, panoramic radiographic 
analysis showed good specificity and low sensitivity.32 Cone-beam computed 
tomography provides and medical-grade CT provide 3D alternatives to panoramic 
radiography that enable clinicians to more accurately diagnose TMJ pathology and 
treat them appropriately. CBCT scans as an alternative for the 2-D imaging. 
Although CBCT images the images are of relatively high quality, the scanners are 
more expensive than a typical Panorex unit and expose patients to more radiation. 
Additionally, the scatter of radiation caused by the presence of metal significantly 
affects CBCT images.    Thus, in individuals with numerous metallic dental 
restorations, implants or orthodontic appliances, artifacts are generated in CBCT 
images that can influence their diagnostic accuracy and limit a clinician’s ability to 
evaluate minor changes within the joint.   
 
When an osseous lesion cannot be accurately defined by the previously mentioned 
modalities, MRI represents the next alternative. It has the ability to detect lesions 
within the soft tissues of the TMJ and can therefore provide additional critical 
information beyond acquired from panoramic radiographs or CBCT. It has been 
shown that MRI can be utilized for assessment of bisphosphonate-related 
osteonecrosis, condylar bone marrow edema and ossification within soft tissue 
compartment of the joints.33,34,35 
 
As suggested earlier in this review, functional imaging techniques have the 
potential to identify early stages of a disease process that precede the overt 
structural changes demonstrated by panoramic radiography, CBCT or MRI. Two 
radionucleotide-based methodologies are single positron emission computed 
tomography (SPECT) and positron emission tomography (PET). Both methods 
involve injecting the patient with radioactively labeled substrates after which the 
subject undergoes a CT scan.   The resultant 3D images reveal in a quantifiable 
manner the areas where metabolically active cells associated with a disease process 
took up the tracer. In a study evaluating patients complaining of idiopathic jaw 
pain using SPECT scanning with Tc-99m-methyl diphosphonate (MDP) as the 
tracer, the images from 20 patients were compared to those from age-matched 
control. The scans of 15 patients showed uptake of the tracer in the area of pain 
while 12 control subjects showed increased uptake in their healed TMJ that had 
been successfully treated. The authors concluded that the sensitivity and specificity 
of SPECT bone scans in detecting painful sites were low. These findings suggest 
that SPECT bone scanning with Tc-99m MDP is not indicated as a 
routine imaging procedure for the detection of jaw pathoses.36 Additional 
limitations of SPECT scan are the high number of false positive results, suboptimal 
spatial resolution of images and relative inaccuracy of the quantification of tracer 
uptake.  
Positron emission tomography has become a widely used molecular imaging 
modality for detecting maxillofacial cancerous lesions and monitoring the effect of 
treatment. It is considered a powerful diagnostic tool capable of detecting early 
stages of a pathologic process and disease resolution. Ng and colleagues conducted 
a study evaluating different imaging techniques for their ability to identify oral 
squamous cell carcinoma and found that 18F-FDG-PET had an accuracy of 98.4% 
when compared to 87.1% and 99.2% for CT and MRI, respectively.  The 
sensitivity of 18F-F-FDG for the identification of nodal metastases on a level-by-
level basis was 22.1% higher than that of CT/MRI (74.7% vs. 52.6%, P < 0.001) 
whereas the specificity of 18F-FDG-PET was 1.5% lower than that of CT/MRI 
(93.0% vs. 94.5%, P = 0.345). The authors concluded that 18F-FDG-PET is a 
superior and more sensitive approach for detecting oral SCC. 37 In a systematic 
review and meta-analysis assessing a variety of diagnostic imaging techniques for 
excluding or confirming a diagnosis of chronic osteomyelitis, FDG-PET scans 
were shown to have the highest diagnostic accuracy 96% compared to bone 
scintigraphy and MRI (82% and 84%, respectively).38 In addition, Lee et al 
recently demonstrated that 18F-PET/CT is superior to conventional Tc 99m MDP 
bone scanning when used to diagnose TMD associated with osteoarthritis.39  
finally, PET/CT scans can quantify tracer uptake within metabolically active 
tissues and thus possibly yield an early diagnosis prior to the onset of osseous 
degeneration. Collectively, these properties suggest that PET/CT has great 
potential as a tool for evaluating hard and soft tissue lesions of the TMJ. Of course, 
there are limitations associated with PET. The scans do not readily detect smaller  
lesions (<1 cm in size) nor lesions exhibiting low metabolic activity. Additional 
drawbacks are the cost of scanners and reagents as well as the dose of radiation.  
 
Appreciating that a major component of the pathophysiology of RA is the 
induction of an inflammatory reaction that mediates the destruction of both soft 
and hard tissue within joints we speculate that molecular imaging can be used to 
detect early stages of the disease. It is commonly accepted that the definitive 
diagnosis of TMJ disease cannot be based on clinical examination alone.17,18  Thus, 
future research should be conducted to critically determine whether molecular 
imagining techniques such as PET can be used to detect inflammatory changes in 
the joint prior to the onset of structural breakdown.  
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Introduction:  
Rheumatoid Arthritis (RA) is a systemic chronic inflammatory disease that affect 
body joints by inflammation of synovial tissue and destruction of bone and 
cartilage. It is considered as an autoimmune disease that has various serological 
finding that may appears before clinical manifestations 1,2. It manifested clinically 
by swelling, tenderness, increased inflammatory activity, degenerative changes and 
disability 3,4. In clinical examination, rheumatologists have been widely using 
disease activity score of 28 joints using erythrocyte sedimentation rate (DAS28-
ESR) and C-reactive protein(DAS28-CRP) to quantify the disease activity as well 
as assessment to treatment responses5,6.   
Temporomandibular joint (TMJ) is a dynamic joint that is formed by the 
articulation of articular eminence and articular fossa of temporal bone superiorly 
and the condylar head of the mandible inferiorly. In addition, TMJ is considered a 
special joint due to the presence of articular disk between the articulating surfaces 
separating it to upper and lower compartment. Unlike other body joint, TMJ 
articulating surfaces is covered by fibrous connective tissue with presence of 
cartilaginous cell 8,9. TMJ plays an important part in daily activity such as chewing, 
speaking and swallowing. When TMJ is involved in RA it can result in patient 
discomfort, crepitation, stiffness and limitation in mouth opening 4.  Garrot in 1859 
was the first to describe involvement of TMJ in rheumatic disease 13.  Affection of 
TMJ in RA has been reported with a prevalence ranging from 10- 58 %8.9. It can be 
examined clinically and radiographically, structural imaging modalities are used to 
evaluate TMJ involvement including Panoramic X-ray which provides a 2-
dimensional information limited to the osseous structure of the joint. Also, 
computed tomography (CT) and con-beam computed tomography (CBCT) 
considered as the gold standard in terms of TMJ imaging. As it shows 3-
dimnsional image of osseous changes within the joint with good accuracy and 
resolution.  Moreover, magnetic resonance imaging (MRI) can be used to delignate 
soft tissue abnormities in the joint14.  
Molecular imagining approaches such as positron emission tomography (PET) 
assessing TMJ in RA patients hasn’t been widely investigated. Such technique 
offer an alternative that might demonstrate inflammatory changes in the joint prior 
to the onset of structural breakdown.  The ability of 18F-sodium fluoride (NaF) and 
18F-fluorodeoxyglucose (FDG) to assess metabolic activity in osseous structure and 
soft tissue of the joint respectively, has been reported in the other body joints 17,26. 
The aim of this study was to investigate the role of NaF and FDG- PET/CT 
imaging of the TMJ taken in cohorts of RA and control (non-rheumatoid arthritis) 
subjects. 
Material and methods: 
 
 Scans of RA patients were obtained from the Corporal Michael J. Crescenz 
Veterans Affairs Medical Center in Philadelphia. While, control subjects scans 
were part of the “Cardiovascular Molecular Calcification Assessed by 18F-NaF 
PET/CT (CAMONA) study”. The CAMONA study was approved by the Danish 
National Committee on Health Research Ethics and conducted following the 
principles of the Declaration of Helsinki. All study participants provided written 
informed consent. Eighteen patients diagnosed with RA (mean age 55±12.1years: 
4 females and 14 males) were included in the test group. Control group includes 18 
subjects age and gender- matched selected from the CAMONA clinical trial (mean 
age 56±12 years). Clinical data including Disease Activity Score of C-reactive 
protein (DAS28-CPR) and erythrocyte sedimentation rate (DAS28-ESR) were 
calculated for RA patients. 
 
Included test group diagnosed with RA according to the 2010 American College of 
Rheumatology classification criteria for RA. Exclusion criteria included: patient 
with evidence of active malignancy, metabolic bone disease, or recent computed 
tomography (CT) imaging within 6 months (due to concerns about radiation 
exposure). Inclusion criteria in control group were:  patients free of oncological 
disease, autoimmune disease, immunodeficiency syndromes, alcohol abuse, illicit 
drug use, symptoms suggesting cardiovascular disease, or any prescription 
medication patients evaluated for chest pain syndromes were recruited from those 
referred for coronary CT angiography. Also, subjects with a 10-year risk of fatal 
cardiovascular disease included.  Pregnant women were not included in the 
study.22,23  
Imaging protocol: The imaging protocol performed on the PET/CT system. After 
180 minutes of intravenous injection of (4.0 MBq/kg) of F-FDG per kilogram of 
body weigh 18F-FDG PET/CT scan obtained. Within an average of two weeks 18F-
NaF were taken. PET/CT images were acquired 90 minutes post intravenous 
administration of NaF (2.2 MBq/kg).  For attenuation correction and anatomical 
variation low–dose CT imaging (140 kV, 30 – 110 mA, noise index 25, 0.8 s per 
rotation, slice thickness 3.75 mm) was taken.  
Image analysis:  To analyze soft tissue within the joint, Regions of interest (ROIs) 
of FDG scans were manually assigned per predetermined anatomical criteria. The 
first ROI of the mask was assigned on the trans-axial CT slice with the first 
evidence of the glenoid fossa. The ROI followed the anatomy of TMJ where it 
bounded anteriorly by articular eminence of temporal bone, posteriorly by 
tympanic portion of temporal bone, medially by sphenoid bone and laterally by the 
root of zygomatic process of temporal bone (Figure 1). In addition, ROI included 
the head of condyle where it forms the inferior border articulating surface of TMJ. 
ROI were taken in transverse section in two to three consecutive slices for both 
right and left joint. Making sure that the mask included the capsular soft tissue 
excluding bony boundaries.  
For NaF scans, ROI were assigned to ensure involvement osseous compartment of 
the joint. A 3D ball tool of 1.5 cm was used, where the head of the mandibular 
condyle was located at the center of ROI including the osseous compartment of the 
joint extending inferiorly to the neck of the condyle (Figure 2). Averaged 
SUVmean of the right and the left TMJ was used to semi-quantify FDG and NaF 
uptake in the joint.  SUVmean was calculated based on the following equations: 
Total Tissue Metabolism =  ∑ (Slice SUV
mean
* Slice ROIvolume) 
 
Averaged SUVmean =  
Total Tissue Metabolism
ROItotal_volume
 
For normalization, the target-to-background ratio (TBR) was calculated for each 
subject by dividing the average TMJ SUVmean by the SUVmean in the superior 
vena cava taking by assigning ROI of 0.5 cm in the lumen of the vein. The scans 
were independently analyzed twice by the same investigator and second 
investigator for intra/interobserver agreement.  
 
Statistical Analysis: student’s t-test was used for parametric analysis to compare 
SUVmen and TBRmean in RA and control subjects. linear regression analysis was 
used to evaluate the correlation between TMJ uptake and clinical disease activity 
scores. Intraclass correlation coefficient test was used to calculate intra/ 
interobservers agreement. The analysis conducted using IBM SPSS Statistics 
version 25.0 (IBM Corp. Released 2017. IBM SPSS Statistics for Macintosh, 
Version 25.0. Armonk, NY: IBM Corp). 
 
Result: 
Subjects demographic and clinical characteristics are presented in (table 1). High 
level of agreement in both intraobserver and interobserver analysis was found in 
evaluating PET/CT scan of the TMJ (0.99 and 0.97 respectively). The FDG 
average SUVmean of RA patients was 1.18±0.47 compared to 1.09±0.27 in 
healthy controls (p=0.48). FDG TBRmean for the test group was 1.21±0.33 
compared to 0.91±0.2 in controls, (p=0.003.) (Figure 3). No correlation was found 
between FDG TBRmean and DAS28-CRP or DAS28-ESR. The NaF average 
SUVmean was significantly higher in RA patients than healthy control subjects 
(2.4±0.8 versus 1.9±0.4, p=0.02). Similarly, the TMJ TBRmean was also higher in 
RA patients relative to healthy controls (4.2±2.1 versus 2.7±0.9, p=0.01).  A 
significant positive correlation was found between TBRmean and DAS28-CPR 
(r=0.49, p=0.03), while an insignificant one was observed between DAS28-ESR 
(r=0.37, p=0.12) (Figure 4).  
 
 
Discussion:  
The result of our study illustrates that higher TMJ metabolic activity in RA patients 
when compared to age/gender matched non-arthritis subjects. Which was 
determined by the significant TMJ TBRmean of FDG (1.21±0.33 vs 0.91±0.2, 
p=0.003) and NaF (4.2±2.1 versus 2.7±0.9, p=0.01).  Our finding is in agreement 
with what have been reported in the literature of involvement of TMJ in 
rheumatoid arthritis with a prevalence up to 58%.9  
RA is an autoimmune inflammatory disease of multifactorial origin. The 
underlying cause of RA is still poorly defined.    Inflammation of synovial fluid 
and degenerative joint changes are among the reported characteristics of the 
disease. Cartilage erosion and progressive bone degeneration affect the articular 
surface and bony structure of TMJ. Proinflammatory cytokines reported to be in a 
higher level in RA including IL1, IL6 and TNF. 20,21 FDG can detect molecular 
metabolic activity within the soft tissue component of the joint. In this study the 
ROI for FDG analysis were manually drawn to including as much of the soft tissue 
within the joint trying to exclude adjacent bony structures. While NaF, evaluate 
uptake in the osseous compartment, analysis in our method included the head of 
the condyle and articular surface of temporal bone with a goal to assess potential 
bony destruction.  
Radiographic analysis is an essential armamentarium in diagnosing and monitoring 
treatment responses of TMJ disorders. Many studies have verified the utility of 
NaF and FDG-PET/CT in assessing osteoarthritis changes in other body joints. 17 
Lee et al. were also able to demonstrate that PET has scan higher sensitivity and 
accuracy when compared to conventional bone scan for detecting TMD with 
osteoarthritis18. Moreover, in a systematic review of imaging techniques evaluating 
chronic osteomyelitis, FDG-PET imaging demonstrated the highest diagnostic 
accuracy 92% compared with 82% bone scintigraphy, and 84% MRI 19.  In 
evaluating arthralgic TMJs, SUVmax using NaF PET/CT was consistently showed 
to have a fair performance it detection and exclusion of affected joints. Moreover, 
SUVmax was significantly higher values in the temporomandibular joints in 
subtypes 4 than in the other subtypes. The study found out that NaF PET/CT is 
superior to 99m Tc-HDP SPECT/CT in regards to regarding the measurement of 
SUVmax as a diagnostic criterion for TMD15,16.  
Since, diseases usually occur at cellular level before destructive changes appear 
clinically or radiographically. PET scan could be an asset in terms of detecting and 
objectively assessing changes at molecular level. This could an essential way of 
managing disease at its early stages before structural breakdown takes place. But, 
research regarding the practical application of PET/CT in TMJ disorder is lacking.  
Evaluating the disease activity score, we found correlation between DAS28-CRP 
& DAS28-ESR and NaF TBRmean (r=0.49, p=0.03 & r=0.37, p=0.12, 
respectively). But no correlation was found between activity score and FDG 
TBRmean. This finding could be attributed to the differences in disease initiation 
of RA patients included in this study. Another potential explanation is that osseous 
destruction is more pronounced in the joint of RA patients than soft tissue 
inflammation. In animal studies, Irmler et al. was able to demonstrate that Naf and 
FDG was correlated with joints distraction. NaF uptake was a sustained after 11 
days of disease initiation with significant increase in uptake between day 18 and 
25. While FDG uptake reached its peak at day 13 followed by subsequent 
reduction at day 21. Thus, indicating that inflammation is followed by bone 
destruction. 24,25 
Among the limitation of the current study, is the small sample size of population. 
Also, our quantitative results lack the clinical information related to TMJ analysis 
such as pain, crepitation or limitation of mouth opening that could have supported 
our results. In addition, TMJ is a small joint which requires a high-resolution 
imaging modalities to define anatomical boundaries in a precise manner. However, 
the main purpose of this study was to develop an analysis scheme for quantifying 
TMJ with PET/CT scan and it has shown a promising sensitivity to detect the 
activity of inflammation and bone turn over. This will aid in achieving an earlier 
disease diagnosis and provide an objective tool to follow disease activity and 
progression as well as evaluate response to treatment approaches. Future 
longitudinal studies with larger sample size and clinical information of TMJ 
disease severity are required to quantify degenerative changes within the joint.  
 
 
Conclusion:  
 
Our results illustrate the potential value of using FDG and NaF-PET/CT for 
evaluation of TMJ disorders and other inflammatory conditions within the oral 
cavity. Since this approach yields structural images along with data that can be 
quantified it provides more information than conventional structural imaging 
techniques. The RA patients appeared to have significantly higher metabolic 
activity in the TMJ relative to the healthy control subjects. The degree of NaF 
uptake in the TMJ correlated with biochemical parameters of RA disease severity 
based on DAS28-CRP and DAS28-ESR scores.  Thus, the results suggest that NaF 
uptake does have the capacity to detect inflammatory changes prior to overt 
structural breakdown of the joint. In the future, this could allow for earlier and 
more efficacious treatment of degenerative disorders affecting the TMJ. 
Furthermore, NaF-PET/CT might also serve as a means of objectively assessing 
treatment outcomes especially those aimed at regeneration of damaged components 
of the TMJ. 
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 RA Control 
n 18 18 
Age years (mean±SD) 57±12 56±12 
Female gender n (%) 4/18 (22.2%) 4/18 (22.2%) 
BMI (mean±SD) 26.9 ±6 27± 3.4 
Disease duration n  (%) 12.5 (11.1) 
 
 
TJC, median (min, max)  
6.5 (0, 15) 
 
 
SJT median (min, max) 6 (0, 6.5) 
  
 
DAS28-ESR (mean ±SD)  
 
4.4 ±1.6 
 
 
DAS28-CRP (mean ±SD)  
 
3.74 ±1.3 
 
 
 
 
 
Table 1: Patients’ demographic and clinical characteristics; Min: minimum; max, maximum; TJC: tender 
joint count; SJC, swollen joint count; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; 
DAS28, Disease Activity Score based on 28 joint count. 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 1: ROI was manually drawn following the anatomical boundaries of the TMJ and is here  
shown as it appears on the trans-axial slice on the fused (a) and the PET (b) images.  
 
 
 
 Figure 3 : Box plots of the average FDG SUVmean (a) and TBRmean (b) of RA patients compared tohealthy 
control. 
 
 Figure 2: ROI including the osseous compartment of TMJ in transvers, sagittal and coronal slice of a fused 
 PET/CT scan. 
 
0
0.5
1
1.5
2
2.5
RA Control
SU
V
m
ea
n
0
0.5
1
1.5
2
2.5
RA Control
TB
R
m
ea
n
*
 Figure 4:  Box plots of the average NaF SUVmean (a) and TBRmean (b) of RA patients compared to 
healthy control. (c,d). The assossiation between TBRmean with DAS28-CPR and DAS28-ESR. 
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